Not Yet RecruitingNCT07546396
Methadone Rapid Restart
Medication studyAges 19+CanadaAddiction
Understand this study
Who could participate?
Listed age limits: from 19 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: May 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 25
- Sponsor
- Pouya Azar
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 19 Years
- Official registry ID
- NCT07546396
- Official title
Show the full official title
Methadone Rapid Restart Study
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pouya Azar.
Does this study involve medication?
Yes. The study involves medication, including Methadone.
Who can participate?
Listed age limits: from 19 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
Want to explore more studies?
Explore studiesRelated studies
Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)
Tirzepatide in the Treatment of Addiction